| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |